Dermatology

Azitra demonstrates feasibility of engineering the skin microbiome to treat serious skin conditions

Takeda touts superior remission rates in ulcerative colitis trial

Three companies and their dealmaking recently

Biotec Pharmacon awarded grant from Research Council of Norway to develop next-generation wound product

Histofluor Rodent Tissue Slides receive FDA 510(k) clearance

CAMP-1 and CAMP-2 trials for molluscum contagiosum both achieve statistical significance for the primary endpoint with p-values less than 0.0001

Concert reveals results for drug to counter autoimmune attack against hair follicles

Companies continue efforts to develop tests for early Alzheimer’s diagnosis

Promentis Pharmaceuticals announces successful completion of Phase 1 studies for SXC-2023 targeting novel glutamatergic mechanism

Mouse study identifies rare example where being older improves tissue function, helping skin heal with less scarring

KB103 yields functional collagen production and sustained wound healing in chronic blistering patients

Metrion Biosciences awarded funding under Innovate UK Biomedical Catalyst Primer Award